Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Contested technologies [[electronic resource] ] : xenotransplantation and human embryonic stem cells / / Anders Persson & Stellan Welin
| Contested technologies [[electronic resource] ] : xenotransplantation and human embryonic stem cells / / Anders Persson & Stellan Welin |
| Autore | Persson Anders |
| Pubbl/distr/stampa | Lund, Sweden, : Nordic Academic Press, 2008 |
| Descrizione fisica | 1 online resource (213 p.) |
| Disciplina | 617.95 |
| Soggetto topico |
Xenografts
Embryonic stem cells |
| Soggetto genere / forma | Electronic books. |
| ISBN | 91-87121-79-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Copyright; Contents; Preface; 1. Background, positions, controversies; 1.1 The rise of molecular medicine; 1.2 Aims and limitations of the book; 1.3 Theoretical perspectives and central concepts; 1.4 The role of the observer; 1.5 Methods and material; 1.6 Outline of the book; 2. Xenotransplantation: development and controversies; 2.1 Introduction; 2.2 A short history of xenotransplantation; 2.3 Regulative efforts; 2.4 PERV and the call for a worldwide moratorium; 2.5 The lobbyists: patient organisations and animal rights activists; 2.6 The controversy in the political arena
2.7 The boundaries of the human body2.8 Knock-out pigs and some recent developments; 3. The ethics of early clinical trials; 3.1 The research regime: science versus ethics; 3.2 The Baby Fae case, or, was xenotransplantation premature?; 3.3 The last primate trials and the risk of viral infections; 3.4 Pig islets to diabetes patients: from low-risk research to PERV risk; 3.5 Extra-corporal transfusion through pig kidneys; 3.6 Going south: the Valdés-González case; 3.7 The way forward; 4. Human embryonic stem cells: developments and debates; 4.1 Human embryonic stem cells and the embryo 4.2 The British embryo research debate4.3 The Swedish debate on hESC research; 4.4 Rhetorical strategies; 4.5 A Presidential decision and its consequences; 4.6 Avoiding the human embryo: adult stem cells; 4.7 The end of controversy? An American epilogue; 5. The commercialisation of biomedical science; 5.1 The changing landscapes of biomedical research funding; 5.2 The role of patents and the control of biological material; 5.3 The commercialisation of stem cell research; 5.4 The Swedish stem cell companies; 5.5 Commercialisation and research ethics; 5.6 Science by press release 5.7 Science on the run5.8 Some concluding remarks; 6. Summing up: risk, therapies, values, and vested interests; 6.1 The xenotransplantation and hESC controversies compared; 6.2 The involvement of commercial interests; 6.3 Involving the public: consultations, surveys, and social consent; 6.4 The therapeutic imperative and global inequality; References |
| Record Nr. | UNINA-9910453224403321 |
Persson Anders
|
||
| Lund, Sweden, : Nordic Academic Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Contested technologies [[electronic resource] ] : xenotransplantation and human embryonic stem cells / / Anders Persson & Stellan Welin
| Contested technologies [[electronic resource] ] : xenotransplantation and human embryonic stem cells / / Anders Persson & Stellan Welin |
| Autore | Persson Anders |
| Pubbl/distr/stampa | Lund, Sweden, : Nordic Academic Press, 2008 |
| Descrizione fisica | 1 online resource (213 p.) |
| Disciplina | 617.95 |
| Soggetto topico |
Xenografts
Embryonic stem cells |
| Soggetto genere / forma | Electronic books. |
| ISBN | 91-87121-79-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Copyright; Contents; Preface; 1. Background, positions, controversies; 1.1 The rise of molecular medicine; 1.2 Aims and limitations of the book; 1.3 Theoretical perspectives and central concepts; 1.4 The role of the observer; 1.5 Methods and material; 1.6 Outline of the book; 2. Xenotransplantation: development and controversies; 2.1 Introduction; 2.2 A short history of xenotransplantation; 2.3 Regulative efforts; 2.4 PERV and the call for a worldwide moratorium; 2.5 The lobbyists: patient organisations and animal rights activists; 2.6 The controversy in the political arena
2.7 The boundaries of the human body2.8 Knock-out pigs and some recent developments; 3. The ethics of early clinical trials; 3.1 The research regime: science versus ethics; 3.2 The Baby Fae case, or, was xenotransplantation premature?; 3.3 The last primate trials and the risk of viral infections; 3.4 Pig islets to diabetes patients: from low-risk research to PERV risk; 3.5 Extra-corporal transfusion through pig kidneys; 3.6 Going south: the Valdés-González case; 3.7 The way forward; 4. Human embryonic stem cells: developments and debates; 4.1 Human embryonic stem cells and the embryo 4.2 The British embryo research debate4.3 The Swedish debate on hESC research; 4.4 Rhetorical strategies; 4.5 A Presidential decision and its consequences; 4.6 Avoiding the human embryo: adult stem cells; 4.7 The end of controversy? An American epilogue; 5. The commercialisation of biomedical science; 5.1 The changing landscapes of biomedical research funding; 5.2 The role of patents and the control of biological material; 5.3 The commercialisation of stem cell research; 5.4 The Swedish stem cell companies; 5.5 Commercialisation and research ethics; 5.6 Science by press release 5.7 Science on the run5.8 Some concluding remarks; 6. Summing up: risk, therapies, values, and vested interests; 6.1 The xenotransplantation and hESC controversies compared; 6.2 The involvement of commercial interests; 6.3 Involving the public: consultations, surveys, and social consent; 6.4 The therapeutic imperative and global inequality; References |
| Record Nr. | UNINA-9910540175403321 |
|
Persson Anders
|
||
| Lund, Sweden, : Nordic Academic Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||